Overview

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the pharmacokinetics, safety and efficacy of an octreotide implant for the treatment of the symptoms of carcinoid syndrome.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Octreotide